OVERVIEW
The global medical exoskeleton market size is projected to reach USD 612.2 million by 2024, growing over the forecast period at a CAGR of 36.2%. The growth of the medical exoskeleton market is driven by factors such as the growing number of people with physical disabilities and subsequent growth in demand for effective rehabilitation approaches and rising insurance coverage for medical exoskeletons in several countries.
TABLE OF CONTENT
1 Global Medical Exoskeleton Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Medical Exoskeleton Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Medical Exoskeleton Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Medical Exoskeleton Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Medical Exoskeleton Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Medical Exoskeleton Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Medical Exoskeleton Market – By Component (Market Size – & million/billion)
8.1 Hardware
8.2 Sensors
8.3 Actuators
8.4 Power Sources
8.5 Control Systems
8.6 Other Hardware Components
8.7 Software
9 Global Medical Exoskeleton Market – By Type
9.1 Powered Exoskeletons
9.2 Passive Exoskeletons
10 Global Medical Exoskeleton Market – By Extremity
10.1 Upper Extremity Medical Exoskeletons
10.2 Lower Extremity Medical Exoskelet
11 Global Medical Exoskeleton Market – By Mobility
11.1 Stationary Exoskeletons
11.2 Mobile Exoskeletons
12 Global Medical Exoskeleton Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Medical Exoskeleton Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Medical Exoskeleton Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Cyberdyne
14.3 Ekso Bionics Holdings
14.4 Rewalk Robotics
14.5 Bionik Laboratories
14.6 Rex Bionics
14.7 Hocoma AG (A Subsidiary of DIH Technologies)
14.8 Wearable Robotics
14.9 Parker Hannifin
14.10 B-Temia
14.11 Bioness
14.12 Company 11 & more
15 Global Medical Exoskeleton Market – Appendix
15.1 Sources
15.2 Abbreviations